About Author

3 kommentarer

  1. Ifølge leserunden min ikveld så skjer det mer:
    SITAT: Based on the current study, there is now a Norwegian national initiative to do a randomized, blinded, multicenter Phase III study to verify or reject the conclusions of the PLoS One study. In the planning of this national study, results of our exploratory phase II study with Rituximab induction and maintenance will be important for the scheduling of the drug administration. /sitat slutt herfra: http://www.meassociation.org.uk/?p=8639
    Det høres iallfall positivt ut 😀

Leave A Reply

Dette nettstedet bruker Akismet for å redusere spam. Lær om hvordan dine kommentar-data prosesseres.